PetMed Express (PETS) announced the appointment of Peter Batushansky to the Company’s Board of Directors, effective April 9. Mr. Batushansky is currently a Partner at L2 Capital Partners and brings to the Board more than 20 years of experience across retail, pet, healthcare and private equity, including executive leadership roles at WebEyeCare and Allivet. Gian Fulgoni, longtime board member and former Chairman, has communicated his intention to retire from the Board when his term expires at the 2025 annual shareholders’ meeting. With the appointment of Batushansky, the Board will be comprised of seven directors, six of whom are independent, and three of whom have been added since 2024.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PETS:
- PetMed Express Earnings Call Highlights Profitability Amid Sales Challenges
- Morning Movers: Lattice Semiconductor, SelectQuote jump after earnings reports
- PetMed Express Shows EBITDA Growth Amid Transformation
- Closing Bell Movers: Lattice Semi up 13% on earnings
- PetMed Express reports Q3 EPS (3c) vs. (10c) last year